Medical Doctor Program year 2019 Source: CMS Open Payments, 2026 publication

Timothy Moriarty

General Practice Panama City, FL Medical Doctor

NPI 1578539805 CMS profile 116420

221 E 23Rd St, Suite B, Panama City, FL 32405

Open in the dashboard

General payments

$1,569

39 records reported · program year 2019

Research payments

$1,189

Paid to them · 12 records reported · program year 2019

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$646,409 paid to institutions, not to them · program years 2019–2021

Through program year 2019, Timothy Moriarty of Panama City, FL is reported in the CMS Open Payments database as having received $1,569 across 39 general payments and $1,189 in research payments paid to them. Separately, studies naming them as principal investigator received $646,409 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2019 General $1,569 39
2019 Research $1,189 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Moriarty
  • General Practice median
  • Middle half of General Practice
  • National median

In program year 2025, general payments to Timothy Moriarty were reported at $0. Among 4,774 General Practice profiles paid that year, the median was $106 and the middle half received between $35 and $292.

Show as a table
Year Timothy Moriarty General Practice median Middle half National median
2019 $1,569 $107 $37–$285 $163
2020 $0 $75 $25–$213 $114
2021 $0 $93 $30–$272 $132
2022 $0 $103 $36–$279 $149
2023 $0 $106 $34–$276 $160
2024 $0 $114 $39–$290 $164
2025 $0 $106 $35–$292 $169

Breakdown

Who paid General payments · program year 2019
  1. AstraZeneca Pharmaceuticals LP $999 11 payments
  2. GlaxoSmithKline, LLC. $334 18 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $162 6 payments
  4. Mylan Specialty L.P. $41 2 payments
  5. Genzyme Corporation $19 1 payment
  6. Regeneron Healthcare Solutions, Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program year 2019
  1. Food and Beverage $1,112 37 payments
  2. Travel and Lodging $458 2 payments
Products named General payments · program year 2019
  1. BEVESPI AEROSPHERE $816 4 payments
  2. TRELEGY ELLIPTA $158 8 payments
  3. OFEV $103 3 payments
  4. SYMBICORT $97 6 payments
  5. FASENRA $86 1 payment
  6. BREO $68 4 payments
  7. ANORO $62 3 payments
  8. NUCALA $46 3 payments
  9. Yupelri $41 2 payments
  10. SPIRIVA RESPIMAT $40 2 payments
  11. Other $51 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program year 2019
  1. Sanofi US Services Inc. $1,189 12 payments

Records

51 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other General Practice in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2019

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record